Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06530966
PHASE1

Phase I Study of ICP-332 in Healthy Subjects

Sponsor: InnoCare Pharma Inc.

View on ClinicalTrials.gov

Summary

A multiple ascending dose phase I study of ICP-332 in healthy subjects

Official title: A Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ICP-332 in Healthy Subjects

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2024-07-23

Completion Date

2024-12-25

Last Updated

2024-08-02

Healthy Volunteers

Yes

Interventions

DRUG

ICP-332 Tablets

Eligible patients will receive ICP-332 tablets orally as per the protocol

DRUG

ICP-332 Placebo Tablets

Eligible patients will receive ICP-332 placebo tablets orally as per the protocol

Locations (1)

Pharmaron CPC Inc.

Baltimore, Maryland, United States